SEC Tracker
Get the app

Lycia Therapeutics LYCA

Lycia Therapeutics: Securities offering (amended)

Securities offering (amended)

Form
S-1/A
Filed
Importance
Routine
  1. 14,700,000 shares of common stock offered
  2. IPO price expected between $16.00 and $18.00 per share
  3. Application to list on Nasdaq under LYCA

Written from the S-1/A on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Lycia Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2836) and public float not reported.

  1. Adaptimmune Therapeutics ADAP
  2. Adverum Biotechnologies ADVM
  3. AgomAb Therapeutics AGMB
  4. Alvotech ALVO
  5. Argenx ARGX